CCR7 and graft versus host disease: Indeed, CCR7 gene engineering of MSCs has been shown to improve their immunomodulatory effect when used as therapy for GvHD.149 Nevertheless, the safety of gene vectors used in modification should be optimized to minimize their impact on the function of MSCs.